Back to results
US 7,744,590 B2Granted
Red to near-infrared photobiomodulation treatment of the visual system in visual system disease or injury
AssigneeThe Medical College of Wisconsin Research Foundation, Inc.
InventorsJanis T. Eells, Margaret T. T. Wong-Riley, Harry T. Whelan
Life of this patent
Estimating the term…
Abstract
A method of treating visual system disease is disclosed. One embodiment comprises the steps of (a) exposing a component of a patient's visual system to light treatment, wherein the light treatment is characterized by wavelength of between 630-1000 nm and power intensity between 10-90 mW/cm2 for a time of 1-3 minutes, and (b) observing restoration of visual system function.
Claims19
A method of treating visual system disease or injury, comprising the steps of
- a) exposing a component of a patient's visual system to light treatment in the absence of an exogenous photosensitizer, wherein the light treatment is characterized by a wavelength of 630-1000 nm and power intensity between 10-90 mW/cm2, and
- b) performing one or more tests measuring visual function, wherein the test results indicate an increase in metabolically active neurons.
A method of treating visual system disease or injury, comprising the steps of
- a) exposing a component of a patient's visual system to light treatment in the absence of an exogenous photosensitizer, wherein the light treatment is characterized by wavelength of 630-1000 nm and power intensity between 10-90 mW/cm2, and
- b) performing electroretinography (ERG) to observe restoration or protection of visual function, wherein rod and cone ERG amplitude has increased relative to tissue that hasn't been exposed to the light treatment.
Dependencies are inferred from the claim text.